Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Western Blot: SARS Nucleocapsid Protein Antibody (8G8A) [NBP3-07064] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid Protein and Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [8G8A], NBP3-07064, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-Nucleocapsid-Protein-Antibody-8G8A-Western-Blot-NBP3-07064-img0001.jpg "Western Blot: SARS Nucleocapsid Protein Antibody (8G8A) [NBP3-07064] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid Protein and Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [8G8A], NBP3-07064, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8) [NBP3-05729] - Validation of SARS-CoV-2 Nucleocapsid AntibodyLane 1: 50ng, Lane 2: 25ng, Lane 3: 5ng, Lane 4: 2ng , Lane 5: 1ng and Lane 6: 0.5ng of SARS-CoV-2 N protein probed with SARS-CoV-2 Nucleocapsid Antibody [6A8], at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-6A8-Western-Blot-NBP3-05729-img0001.jpg "Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8) [NBP3-05729] - Validation of SARS-CoV-2 Nucleocapsid AntibodyLane 1: 50ng, Lane 2: 25ng, Lane 3: 5ng, Lane 4: 2ng , Lane 5: 1ng and Lane 6: 0.5ng of SARS-CoV-2 N protein probed with SARS-CoV-2 Nucleocapsid Antibody [6A8], at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![Western Blot: MERS-CoV Nucleoprotein Antibody [NBP3-16057] - Analysis of extracts of MERS-CoV Nucleoprotein, using MERS-CoV Nucleoprotein antibody (NBP3-16057) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 0.5s.](http://images.novusbio.com/fullsize/MERS-CoV-Nucleoprotein-Antibody-Western-Blot-NBP3-16057-img0001.jpg "Western Blot: MERS-CoV Nucleoprotein Antibody [NBP3-16057] - Analysis of extracts of MERS-CoV Nucleoprotein, using MERS-CoV Nucleoprotein antibody (NBP3-16057) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 0.5s.")
![Western Blot: SARS Nucleocapsid Protein Antibody (14B3D) [NBP3-07063] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid protein, Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [14B3D], NBP3-07063, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.](http://images.novusbio.com/fullsize/SARS-Nucleocapsid-Protein-Antibody-14B3D-Western-Blot-NBP3-07063-img0001.jpg "Western Blot: SARS Nucleocapsid Protein Antibody (14B3D) [NBP3-07063] - Western Blot Validation of SARS Nucleocapsid Antibody. Lane 1: SARS-CoV-2 Nucleocapsid protein, Lane 2: recombinant SARS Nucleocapsid protein, Lane 3: MERS Nucleocapsid protein probed with SARS Nucleocapsid Antibody [14B3D], NBP3-07063, at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.")
![ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - No cross-reactivity in ELISA with MERS-CoV Nucleoprotein protein and SARS Coronavirus Nucleocapsid.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-ARC5077-02-Azide-and-BSA-Free-ELISA-NBP3-05765-img0002.jpg "ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - No cross-reactivity in ELISA with MERS-CoV Nucleoprotein protein and SARS Coronavirus Nucleocapsid.")
![ELISA: SARS-CoV-2 Nucleocapsid Antibody (ARC5077-02) - Azide and BSA Free [NBP3-05765] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-ARC5077-02-Azide-and-BSA-Free-ELISA-NBP3-05765-img0001.jpg)
![Western Blot: SARS-CoV-2 Nucleocapsid Antibody (019) [NBP3-12735] - Lane A: SARS-COV-2 Nucleocapsid overexpressed HEK293 Whole Cell LysateLane B: HEK293 Whole Cell LysateLysates/proteins at 10 ug per lane.SecondaryGoat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilutionDeveloped using the ECL technique.Performed under reducing condition](http://images.novusbio.com/fullsize/SARS-CoV-2-Nucleocapsid-Antibody-019-Western-Blot-NBP3-12735-img0003.jpg "Western Blot: SARS-CoV-2 Nucleocapsid Antibody (019) [NBP3-12735] - Lane A: SARS-COV-2 Nucleocapsid overexpressed HEK293 Whole Cell LysateLane B: HEK293 Whole Cell LysateLysates/proteins at 10 ug per lane.SecondaryGoat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilutionDeveloped using the ECL technique.Performed under reducing condition")